Af de 353 patienter i MM- 009 og MM- 010 studierne, som fik lenalidomid/ dexamethason, var 45, 6% i alderen 65 år og derover.
Out of 353 patients in the MM-009 and MM-010 studies who received lenalidomide/dexamethasone, 45.6% were aged 65 or over.